This is the device they used for the vagus nerve stimulation #ACR19 @rheumnow Abst0930 https://t.co/XGKRjONTqf

2 papers looking at TNFi on radiographic progression in Ankylosing Spondylitis. TNF inhibitor treatment slowed radiologic progression when compared to other therapies but covariables such as smoking and NSAIDs need to be considered #ACR19 @RheumNow

Filgotinib in RA (FINCH3); Another👍🏼 result for JAKi How will we choose which JAKi to use in an increasing crowded space? Any thoughts? #ACR19 @rheumnow Abst0927

@rheumnow #ACR2019 ABS857 Stdy of 21 SLE pts received allogenic mesench stem cells IV ⬇️ inflamm through upregulation of periph tolerogenic CD1c+ DC, esp in LN. UC-MSCs express FLT3L that binds to FLT3 on CD1c+DCs to promote proliferat&inhibit apoptosis of tolerogenic CD1c+DCs

Over two years, there can be progression of facet joint ankylosis with most progression occurring in the thoracic spine. Whole spine low dose CT is a research tool to study progression of facet joint in radiographic axSpA patients. van Gaalen #ACR19 @rheumnow

#acr19 @rheumnow abstr#0849 #ACRbest French database: Risk for CA in RA with biologics compared to traditional sDMARDS: n= 83,659 1. No ⬆️ risk solid malig 2. HR lymphoma 1.35. p value not sig 3. NO diff CA b/t biologic monoRx vs comb biologic + DMARD *nonmelanomatous skin CA

The discrepancy in diagnosis between rheumatologists and radiologists reflects the increasing insecurity of including only BME of SIJ as the major criterium for diagnosing axSpA. Structural changes are also important. Baraliakos #ACR19 @RheumNow #axialspondyloarthritis

Listening to ⁦@AngusWorthing⁩ talk about what ⁦@ACRheum⁩'s advocacy efforts are doing for their members. #ACR19 @rheumnow https://t.co/aLYPuh0Clr

Semi-axial combined with standard semi-coronal scans in MRI protocols for sacroiliitis improved recognition of non-specific BME, which is in the posterior lower ilium in association with SIJ features, and in the anterior upper sacrum #ACR19 @RheumNow #axialspondyloarthritis

There is a strong association between smoking and MRI-SIJ inflammation over time in axSpA patients with type of work and level of education level irrespective of other socio-economic factors, systemic inflammation and treatment. Nikiphorou #ACR19 @RheumNow

Abstr#0848 @rheumnow #acr19 another study confirming that steroids dose correl to hospitalized infx: from Medicare database https://t.co/6SZqd0A8Xv

Abstr#0846 ⁦@RheumNow⁩ #acr19 #acrbest Eval of MACE and VTE of UPA based on phs 3 trials: 1. NO ⬆️risk MACE/VTE over 2 yrs compared to MTX, ADA 2. NO correl. w/lipid levels, dose of drug with MACE/VTE and UPA. * despite the safety seen, UPA’s label still include VTE risk https://t.co/unOBvoW8Ub

#ACR19 @ElenaNikiUK @RheumatologyUK vaccination: Calabrese suggests we should be more didactic in telling our patients to get the flu and shingles vaccines. I can see a clinic notice going up when I get home!

Nintedanib brought modest benefit to IPF & SSc-ILD, but now ILD in other autoimmune dx as well? Small but real diff in lung volumes, no diff in QOL or acute exac/deaths, diarrhea but largely not limiting in study. Works in absence of alt, but worth it? #ACR19 ABST0374 @RheumNow https://t.co/1CDTgiQkMd

After rituximab use, patients with ANCA-associated vasculitis had increased rates of hypogammaglobulinemia, as compared to patients with RA or CTD. Prednisone>10mg/day may in part account for this association. Dr. Stefanie Wade #ACR19 @rheumnow #Abstr  #ACRBest https://t.co/CPWN2qSI9t